Journal: bioRxiv
Article Title: Non-Redundant Roles of Topoisomerase 2α and 2β in the Cytosolic Replication of Vaccinia Virus
doi: 10.1101/2025.02.05.636656
Figure Lengend Snippet: ( A ) Immunoblot analysis of TOP2A and TOP2B siRNA mediated knockdown. ( B ) Loss of TOP2A and TOP2B results in the reduction and increase in viral DNA production at 5 hpi, respectively. NT represents the non-targeting control siRNA. ( C ) The steady-state levels of intermediate (L4) and late (F13, and A27) viral transcripts are reduced and increased in TOP2A- and TOP2B depleted cells, respectively. ( D ) Immunoblot analysis reveals that loss of TOP2A and TOP2B results in reduced or increased expression of post-replicative viral proteins (L4, F13, and A27), respectively. ( E ) Immunofluorecence analysis reevals assembly of new virions at 8 hours post infection is severely impaired in TOP2A-depleted cells but unaffected by the loss of TOP2B. RFP-A3 is a marker for virion cores (total virus) while extracellular virions associated with the plasma membrane during viral egress were detected using the B5 antibody. Scale bar represent 10 µm. ( F ) Quantification of plaque-forming units (PFU) reveals the production of infectious virions is significantly impaired in TOP2A-but not TOP2B depleted cells. All data in the bar chats are presented as mean ± SEM from at least three biological replicates. Statistical significance was determined using one-way ANOVA followed by Dunnett’s post-hoc test for comparisons between treatment groups and the NT control. n.s. = not significant, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.
Article Snippet: Cells were stained with primary antibodies against TOP2A (Cell Signaling Technology, 12286, 1:250 dilution), TOP2B (Santa Cruz, sc-25330, 1:250), DDX1 (Proteintech, 11357-1-AP, 1:1,000 dilution), RTCB (Proteintech, 19809-1-AP, 1:50 dilution), G3BP1 (Proteintech, 66486-1-Ig, 1:1,000 dilution), FAM98A (Abcam, ab204083, 1:50 dilution), dsRNA (RNT-SCI-10010200, Scicons, 1:1,000 dilution), I3 ( ) (1:1,000 dilution), followed by Alexa Fluor 488 or 568 conjugated secondary antibodies (Invitrogen; 1:500 in blocking buffer).
Techniques: Western Blot, Knockdown, Control, Expressing, Infection, Marker, Virus, Membrane